| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Zaleplon | 5-Oxo-Zaleplon | VE009503 | View CAS 159225-99-7 |
Zaleplon Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Zaleplon | 5-Oxo-Zaleplon | VE009503 | View CAS 159225-99-7 |
| Catalogue No. | VE009503 |
| CAS No. | 159225-99-7 |
| Molecular Formula | C17H15N5O2 |
| Molecular Weight | 321.34 g/mol |
| Parent drug | Zaleplon |
| IUPAC Name | N-(3-(3-cyano-5-oxo-4, 5-dihydropyrazolo[1, 5-a]pyrimidin-7-yl)phenyl)-N-ethylacetamide |
| Synonyms | N/A |
| References | Ebbens, M. M., & Verster, J. C. (2010). Clinical evaluation of zaleplon in the treatment of insomnia. Nature and Science of Sleep, 2, 115–126. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630939/ |
| Status | In-stock |
| ListName | 5-Oxo-Zaleplon |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
